Literature DB >> 24501249

Increased ERK and JNK activation and decreased ERK/JNK ratio are associated with long-term organ damage in patients with systemic lupus erythematosus.

Olga Bloch, Mirit Amit-Vazina, Eli Yona, Yair Molad, Micha J Rapoport.   

Abstract

OBJECTIVE: The activities of two mitogen-activated protein kinases (MAPKs), extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), correlate with disease severity in SLE patients. Whether they are also associated with long-term organ damage is unknown. The aim of the present work was to determine whether impaired expression and activity of ERK and JNK correlate with long-term damage in SLE.
METHODS: The expression of ERK and JNK and their phosphorylated active forms was determined by western blot analysis four times during the first year of follow-up in peripheral blood mononuclear cells from 36 SLE patients. A correlation analysis was performed between ERK and JNK expression and longterm organ damage estimated by the SLICC/ARC Damage Index (SDI) 4 years later.
RESULTS: Mean levels of ERK and JNK activities during the first year correlated with long-term organ damage severity (r = 0.38 and r = 0.35, respectively; P = 0.05). Overall JNK expression increased with the severity of chronic damage (P = 0.01; P = 0.05 for SDI score 2 and 3, respectively). In contrast, overall ERK expression significantly decreased in patients with maximal organ damage (SDI score 3) compared with patients with an SDI score of 2 (P = 0.03). The ERK/JNK ratio decreased by approximately 40% and 30% in patients with an SDI score of 3 as compared with patients without organ damage and healthy controls, respectively.
CONCLUSION: These results demonstrate that early activation of ERK and JNK along with decreased overall ERK expression and reduced ERK/JNK ratio may predict the severity of long-term organ damage in SLE patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24501249     DOI: 10.1093/rheumatology/ket482

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  4 in total

1.  Mechanistic Characterization of RASGRP1 Variants Identifies an hnRNP-K-Regulated Transcriptional Enhancer Contributing to SLE Susceptibility.

Authors:  Julio E Molineros; Bhupinder Singh; Chikashi Terao; Yukinori Okada; Jakub Kaplan; Barbara McDaniel; Shuji Akizuki; Celi Sun; Carol F Webb; Loren L Looger; Swapan K Nath
Journal:  Front Immunol       Date:  2019-05-20       Impact factor: 7.561

2.  Investigating the Molecular Mechanism of Xijiao Dihuang Decoction for the Treatment of SLE Based on Network Pharmacology and Molecular Docking Analysis.

Authors:  Fangzhi Wei; Yitian Song; Aiming Gong; Chengdan Pan; Yanping Zhuang; Xuan Zhang; Minyu Zeng
Journal:  Biomed Res Int       Date:  2022-01-20       Impact factor: 3.411

3.  Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor.

Authors:  Karin Hjorton; Niklas Hagberg; Elisabeth Israelsson; Lisa Jinton; Olof Berggren; Johanna K Sandling; Kristofer Thörn; John Mo; Maija-Leena Eloranta; Lars Rönnblom
Journal:  Arthritis Res Ther       Date:  2018-10-24       Impact factor: 5.156

4.  Blocking GSDME-mediated pyroptosis in renal tubular epithelial cells alleviates disease activity in lupus mice.

Authors:  Guihu Luo; Yi He; Fangyuan Yang; Zeqing Zhai; Jiaochan Han; Wenchao Xu; Jialin Zhang; Lili Zhuang; Yanan Zhang; Yehao Li; Rui Song; Xiaoqing Luo; Jianheng Liang; Erwei Sun
Journal:  Cell Death Discov       Date:  2022-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.